Home Nucleus Biotechnology U.S. Genetic Testing Market to 2032

U.S. Genetic Testing Market to 2032

Overview

The U.S. Genetic Testing Market is expected to reach a 31.31 USD Billion by 2032 and is projected to grow at a CAGR of 24.96% from 2025 to 2032.

Revenue, 2024 (USD Billion)
8.76
Forecast, 2032 (USD Billion)
31.31
CAGR, 2024 - 2032
24.96%
Report Coverage
U.S.

U.S. Genetic Testing Market 2018-2032 USD Billion

U.S. Genetic Testing Market, Key Findings (2025-2032)

Market Growth and Projections:

  • Market Size (2024): 8.76 USD Billion
  • Projected Market Size (2032): 31.31 USD Billion
  • CAGR (2025-2032): 24.96%

Key Findings of U.S. Genetic Testing Market

  • The U.S. Genetic Testing Market was valued at 8.76 USD Billion in 2024.
  • The U.S. Genetic Testing Market is likely to grow at a CAGR of 24.96% during the forecast period of 2024 to 2032.
  • In 2024, the Largest segment Cancer in Diseases Segment accounted for the largest share of the market with a revenue of 3.63 USD Billion
  • The fastest growing segment Diagnostic Testing in Type Segment grew Fastest with a CAGR of 28.57% during the forecast period from 2024 to 2032.

U.S. Genetic Testing Market Scope

U.S. Genetic Testing Market Segmentation & Scope
End User
  • Private Laboratories
  • Laboratory Service Providers
  • Private Clinics
  • Diagnostic Centers
  • Clinics
  • Hospitals
Diseases
  • Others
  • Cystic Fibrosis
  • Huntington's Disease
  • Duchenne Muscular Dystrophy
  • Fragile X Syndrome
  • Rare Genetic Disorder
  • Thalassemia
  • Sickle Cell Anemia
  • Cancer
Type
  • Other Types
  • Carrier Testing
  • Predictive and Presymptomatic Testing
  • New Born Screening
  • Diagnostic Testing
  • Prenatal Testing
Technology
  • Fluorescence In Situ Hybridization (FISH)
  • Others
  • Microarrays
  • Whole Genome Sequencing
  • DNA Sequencing (NGS-Based Testing)
  • Polymerase Chain Reaction

U.S. Genetic Testing Market Data Coverage Insights

Study Period 2024-2032
Base Year 2021
Unit Revenue in USD Billion
Market Value in 2024 8.76 USD Billion
Market Value in 2032 31.31 USD Billion
CAGR (2025-2032) 24.96%
Historic Data 2016-2023
Market Segments Covered End User,Diseases,Type,Technology

Regional Insights:

  • Leading Market (2024-2032): U.S., leading in terms of revenue 8.76 USD Billion in 2024
    • Key Country: U.S., leading in terms of revenue with value of 8,755.11 USD Million in 2024.

Segments and Scope

  • U.S. Genetic Testing Market to 2032, By End User
    • Hospitals is the largest segment in U.S. Genetic Testing Market to 2032 with a revenue of 2.37 USD Billion in the year 2024.
    • Hospitals is the Fastest growing segment in U.S. Genetic Testing Market to 2032 with a Growth rate of 27.80 % in forecast period 2025-2032.
  • U.S. Genetic Testing Market to 2032, By Diseases
    • Cancer is the largest segment in U.S. Genetic Testing Market to 2032 with a revenue of 3.63 USD Billion in the year 2024.
    • Cancer is the Fastest growing segment in U.S. Genetic Testing Market to 2032 with a Growth rate of 26.65 % in forecast period 2025-2032.
  • U.S. Genetic Testing Market to 2032, By Type
    • Prenatal Testing is the largest segment in U.S. Genetic Testing Market to 2032 with a revenue of 3.43 USD Billion in the year 2024.
    • Diagnostic Testing is the Fastest growing segment in U.S. Genetic Testing Market to 2032 with a Growth rate of 25.86 % in forecast period 2025-2032.
  • U.S. Genetic Testing Market to 2032, By Technology
    • Polymerase Chain Reaction is the largest segment in U.S. Genetic Testing Market to 2032 with a revenue of 2.53 USD Billion in the year 2024.
    • Polymerase Chain Reaction is the Fastest growing segment in U.S. Genetic Testing Market to 2032 with a Growth rate of 27.84 % in forecast period 2025-2032.

U.S. Genetic Testing Market Company Share Analysis

 
Company Name Company Share Analysis
PerkinElmer Inc.
Illumina, Inc.
Thermo Fisher Scientific Inc.
Cepheid
Fulgent Genetics
U.S. Genetic Testing Market Company Share Analysis

U.S. Genetic Testing Market Geographical Sales Distribution, 2018-2032 USD Billion

U.S. Genetic Testing Market Geographical Sales Distribution, 2018-2032 USD Billion

U.S. Genetic Testing Market Company Profiling

U.S. Genetic Testing Market Company Profiling

Industry Related Reports

South America Cell And Gene Therapy Thawing Equipment Market
Middle East & Africa Cell And Gene Therapy Thawing Equipment Market
North America Cell And Gene Therapy Thawing Equipment Market
Europe Cell And Gene Therapy Thawing Equipment Market
Asia-Pacific Cell And Gene Therapy Thawing Equipment Market
Argentina Cell And Gene Therapy Thawing Equipment Market
Australia Cell And Gene Therapy Thawing Equipment Market
Belgium Cell And Gene Therapy Thawing Equipment Market
Brazil Cell And Gene Therapy Thawing Equipment Market
Canada Cell And Gene Therapy Thawing Equipment Market
Frequently Asked Questions
The U.S. Genetic Testing Market is segmented based on Segmentation End User,Diseases,Type,Technology.
U.S. Genetic Testing Market was valued at USD 8.76(Revenue in USD Billion) in 2021.
U.S. Genetic Testing Market is projected to grow at a CAGR of 24.96% during the forecast period of 2024 to 2032.
The Cancer segment is expected to dominate the U.S. Genetic Testing Market, holding a largest market share of 3.63 USD Billion in 2024

U.S. Genetic Testing Market Scope

U.S. Genetic Testing Market Segmentation & Scope
End User
  • Private Laboratories
  • Laboratory Service Providers
  • Private Clinics
  • Diagnostic Centers
  • Clinics
  • Hospitals
Diseases
  • Others
  • Cystic Fibrosis
  • Huntington's Disease
  • Duchenne Muscular Dystrophy
  • Fragile X Syndrome
  • Rare Genetic Disorder
  • Thalassemia
  • Sickle Cell Anemia
  • Cancer
Type
  • Other Types
  • Carrier Testing
  • Predictive and Presymptomatic Testing
  • New Born Screening
  • Diagnostic Testing
  • Prenatal Testing
Technology
  • Fluorescence In Situ Hybridization (FISH)
  • Others
  • Microarrays
  • Whole Genome Sequencing
  • DNA Sequencing (NGS-Based Testing)
  • Polymerase Chain Reaction
Frequently Asked Questions
The U.S. Genetic Testing Market is segmented based on Segmentation End User,Diseases,Type,Technology.
U.S. Genetic Testing Market was valued at USD 8.76(Revenue in USD Billion) in 2021.
U.S. Genetic Testing Market is projected to grow at a CAGR of 24.96% during the forecast period of 2024 to 2032.
The estimated market value of the U.S. Genetic Testing Market for final year is USD 31.31 (USD Billion).

U.S. Genetic Testing Market Company Profiling

U.S. Genetic Testing Market Company Profiling
Frequently Asked Questions
The U.S. Genetic Testing Market is segmented based on Segmentation End User,Diseases,Type,Technology.
U.S. Genetic Testing Market was valued at USD 8.76(Revenue in USD Billion) in 2021.
U.S. Genetic Testing Market is projected to grow at a CAGR of 24.96% during the forecast period of 2024 to 2032.
The estimated market value of the U.S. Genetic Testing Market for final year is USD 31.31 (USD Billion).

Related Markets

HAVE A QUESTION?

Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.

BROWSE RELATED PAGES